315 results Stibbe Luxembourg étend son offre de services par la venue de nouveaux associés et counsels au sein des pratiques spécialisées en gestion d’actifs/fonds d’investissement, en droit des sociétés ainsi qu’en droit financier Stibbe renforce ses pratiques spécialisées en droit des sociétés, en droit financier ainsi qu’en gestion d’actifs/fonds d’investissement par la venue de Bernard Beerens, Audrey Jarreton, Edouard d’Anterroches, Victorien Hémery et Dayana Bert. Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Update initiatiefwetsvoorstel introductie instemmingsrecht en aanscherping vaste beloning bankiers Op 25 april 2018 had de Raad van State een kritisch advi het wetsvoorstel voor wijziging Wft. Op 5 juli 2018 volgden publicatie van dit advies, reactie van initiatiefnemers en aangepast wetsvoorstel voor de Tweede Kamer. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Constellium Stibbe advises Constellium N.V. on its offerings of ordinary shares and notes and on its cash tender offers of notes. Stibbe advises Frigoglass Stibbe advises Frigoglass on the completion of its restructuring proces Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises on the IPO of Adyen Stibbe advised the joint global coordinators Morgan Stanley and J.P. Morgan and the other joint bookrunners ABN AMRO, BofA Merrill Lynch and Citigroup on the IPO of Adyen on Euronext Amsterdam. Stibbe advises Pershing Square Stibbe is advising Pershing Square Holdings, Ltd. ("PSH") on a tender offer to purchase up to an aggregate amount of $300 million of PSH’s public shares. Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Stibbe advises B&S Group Stibbe advised B&S Group on its IPO on Euronext Amsterdam. B&S Group is an international wholesaler and distributor of fast-moving consumer goods across a range of niche markets. Nederlandse wetgever besluit tot uitstel ESEF Uit de gewijzigde Europese Transparantierichtlijn en de daarop gebaseerde Gedelegeerde Verordening volgt dat uitgevende instellingen hun jaarlijkse financiële verslaggeving zullen moeten opstellen en algemeen verkrijgbaar stellen in het "ESEF". Lidstaatoptie uitstel ESEF Uit de gewijzigde Europese Transparantierichtlijn (Richtlijn 2013/50/EU) en de daarop gebaseerde Gedelegeerde Verordening (EU) 2018/815 volgt dat uitgevende instellingen hun jaarlijkse financiële verslaggeving zullen moeten opstellen en algemeen verkrijgb Marieke Driessen new partner at Stibbe Stibbe in Amsterdam is proud to welcome Marieke Driessen as a partner in its Financial Markets Group. With Marieke’s arrival, Stibbe’s Financial Markets practice in Amsterdam will grow to six partners as of January 1, 2021. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Pagination Previous page Page 10 Current page 11 Page 12 Page 13 Next page
Stibbe Luxembourg étend son offre de services par la venue de nouveaux associés et counsels au sein des pratiques spécialisées en gestion d’actifs/fonds d’investissement, en droit des sociétés ainsi qu’en droit financier Stibbe renforce ses pratiques spécialisées en droit des sociétés, en droit financier ainsi qu’en gestion d’actifs/fonds d’investissement par la venue de Bernard Beerens, Audrey Jarreton, Edouard d’Anterroches, Victorien Hémery et Dayana Bert.
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Update initiatiefwetsvoorstel introductie instemmingsrecht en aanscherping vaste beloning bankiers Op 25 april 2018 had de Raad van State een kritisch advi het wetsvoorstel voor wijziging Wft. Op 5 juli 2018 volgden publicatie van dit advies, reactie van initiatiefnemers en aangepast wetsvoorstel voor de Tweede Kamer.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Constellium Stibbe advises Constellium N.V. on its offerings of ordinary shares and notes and on its cash tender offers of notes.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises on the IPO of Adyen Stibbe advised the joint global coordinators Morgan Stanley and J.P. Morgan and the other joint bookrunners ABN AMRO, BofA Merrill Lynch and Citigroup on the IPO of Adyen on Euronext Amsterdam.
Stibbe advises Pershing Square Stibbe is advising Pershing Square Holdings, Ltd. ("PSH") on a tender offer to purchase up to an aggregate amount of $300 million of PSH’s public shares.
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.
Stibbe advises B&S Group Stibbe advised B&S Group on its IPO on Euronext Amsterdam. B&S Group is an international wholesaler and distributor of fast-moving consumer goods across a range of niche markets.
Nederlandse wetgever besluit tot uitstel ESEF Uit de gewijzigde Europese Transparantierichtlijn en de daarop gebaseerde Gedelegeerde Verordening volgt dat uitgevende instellingen hun jaarlijkse financiële verslaggeving zullen moeten opstellen en algemeen verkrijgbaar stellen in het "ESEF".
Lidstaatoptie uitstel ESEF Uit de gewijzigde Europese Transparantierichtlijn (Richtlijn 2013/50/EU) en de daarop gebaseerde Gedelegeerde Verordening (EU) 2018/815 volgt dat uitgevende instellingen hun jaarlijkse financiële verslaggeving zullen moeten opstellen en algemeen verkrijgb
Marieke Driessen new partner at Stibbe Stibbe in Amsterdam is proud to welcome Marieke Driessen as a partner in its Financial Markets Group. With Marieke’s arrival, Stibbe’s Financial Markets practice in Amsterdam will grow to six partners as of January 1, 2021.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.